Related Experiment Video
Updated: Dec 28, 2025
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
Drug-Related Carcinogenesis: Risk Factors and Approaches for Its Prevention
G A Belitskiy1, K I Kirsanov2,3, E A Lesovaya1,4
1Blokhin Russian Cancer Research Center, Ministry of Health of Russian Federation, Moscow, 115478, Russia.
Abstract:
The review summarizes the data on the role of metabolic and repair systems in the mechanisms of therapy-related carcinogenesis and the effect of their polymorphism on the cancer development risk. The carcinogenic activity of different types of drugs, from the anticancer agents to analgesics, antipyretics, immunomodulators, hormones, natural remedies, and non-cancer drugs, is described. Possible approaches for the prevention of drug-related cancer induction at the initiation and promotion stages are discussed.
Insights
This review examines how drug metabolism and DNA repair systems influence therapy-related cancer development. Understanding genetic variations in these systems can help predict and prevent drug-induced cancer risk.
Area of Science:
- Pharmacology
- Genetics
- Oncology
Background:
- Therapy-related carcinogenesis is a significant concern.
- Drug-induced cancers arise from complex interactions with cellular systems.
- Polymorphisms in metabolic and repair genes can modify cancer risk.
Purpose of the Study:
- To review the role of metabolic and repair systems in therapy-related carcinogenesis.
- To analyze the impact of genetic polymorphism on cancer development risk.
- To discuss prevention strategies for drug-induced cancers.
Main Methods:
- Literature review of existing data.
- Analysis of drug classes and their carcinogenic potential.
- Examination of genetic polymorphisms in key enzymes and pathways.
Main Results:
- Various drugs, including anticancer agents, analgesics, and hormones, exhibit carcinogenic activity.
- Metabolic and repair system polymorphisms significantly affect individual susceptibility to drug-induced cancer.
- Drug-induced carcinogenesis involves complex interactions at initiation and promotion stages.
Conclusions:
- Metabolic and repair systems are crucial in understanding therapy-related carcinogenesis.
- Genetic variations influence the risk of developing cancer from medical treatments.
- Targeted prevention strategies can mitigate drug-related cancer induction.
More Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
Cancer Prevention
Some...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Treatment Resistant Cancers
Coronary Artery Disease I: Introduction

